Ignite Creation Date:
2024-05-06 @ 1:44 PM
Last Modification Date:
2024-10-26 @ 1:19 PM
Study NCT ID:
NCT04104776
Status:
RECRUITING
Last Update Posted:
2024-02-16
First Post:
2019-09-23
Brief Title:
A Study of CPI-0209 in Patients With Advanced Solid Tumors and Lymphomas
Sponsor:
Constellation Pharmaceuticals
Organization:
Constellation Pharmaceuticals
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Ovarian Clear Cell Carcinoma |
| Advanced Solid Tumor |
| Diffuse Large B Cell Lymphoma |
| Lymphoma T-Cell |
| Mesothelioma Malignant |
| Prostatic Neoplasms Castration-Resistant |
| Endometrial Cancer |
Keywords:
| Name | View |
|---|---|
| Ovarian Clear Cell Carcinoma | View |
| Lymphoma Large B-Cell Diffuse | View |
| Lymphoma B-cell | View |
| Lymphoma T-cell | View |
| Lymphoma Non-Hodgkin | View |
| Lymphoma | View |
| Neoplasms by Site | View |
| Neoplasms by Histologic Type | View |
| Neoplasms | View |
| Lymphoproliferative Disorders | View |
| Lymphatic Diseases | View |
| Immunoproliferative Disorders | View |
| Immune System Diseases | View |
| Topoisomerase Inhibitors | View |
| Molecular Mechanisms of Pharmacological Action | View |
| Antineoplastic Agents | View |
| Endometrial Cancer | View |